The convenience of subcutaneous route of drug administration and the reformulation of intravenous drugs, reaching patent expiry, for SC delivery has provided an impetus to the development of large volume wearable injectors. In fact, according to the experts in this field, the industry is putting in significant efforts to develop efficient and effective drug-device combinations to deliver large volumes of drugs over a convenient period of time.
To order this 540+ page report, which features 175+ figures and 200+ tables, please visit this -https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors/238.html
The USD 2.7 billion and USD 600 million (by 2030) financial opportunity within the large volume wearable injectors market for the delivery of insulin and of non-insulin drugs, respectively, has been analyzed across the following segments:
§ Type of Device
- Patch Pump / Injectors
- Infusion Pump / Injectors
§ Product Usability
- Disposable
- Re-usable
§ Therapeutic Area (for non-insulin drugs)
- Neurological Disorders
- Cardiovascular Disorders
- Oncological Disorders
- Infectious Disorders
§ Key geographical regions
- North America
- Europe
- Asia Pacific
The report Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices.” features the following companies, which we identified to be key players in this domain:
§ Becton Dickinson
§ Bespak (subsidiary of Consort Medical)
§ CeQur
§ Debiotech
§ Eli Lilly
§ Enable Injections
§ Insulet
§ Medtronic
§ PharmaSens
§ Roche
§ SOOIL Development
§ Sonceboz
§ Sensile Medical (acquired by Gerresheimer)
§ SteadyMed Therapeutics (acquired by United Therapeutics)
§ Tandem Diabetes Care
§ Weibel CDS (acquired by SHL Medical)
§ West Pharmaceutical Services
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Large Volume Wearable Injectors: Current Market Landscape
5. Product Competitiveness Analysis
6. Large Volume Wearable Injectors: Key Players
7. Drug Device Combinations: Tabulated Profiles
8. Partnerships and Collaborations
9. Key Acquisition Targets
10. Patent Analysis
11. Large Volume Wearable Injectors: Likely Drug Candidates
12. Emerging Trends on Social Media
13. Clinical Trial Analysis
14. Case Study: Role of CMOs in Device Development and Manufacturing
15. Regulatory and Reimbursement Landscape for Medical Devices
16. Market Sizing and Opportunity Analysis
17. SWOT Analysis
18. Executive Insights
19. Appendix 1: Tabulated Data
20. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors-market-4th-edition-2018-2030/238.html
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Medium - https://medium.com/@RootsAnalysis
Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
